Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective laser trabeculoplasty.

Mark A Latina1, John Mark S de Leon

  • 1Department of Ophthalmology, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, USA. malatina@comcast.net

Ophthalmology Clinics of North America
|August 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation of peripapillary retinal nerve fiber layer and macular ganglion cell-inner plexiform layer in early to moderate glaucoma using the Cirrus ® widefield analysis (PanoMap ® ).

Indian journal of ophthalmology·2023
Same author

A 29-year-old man with bilateral megalocornea.

Digital journal of ophthalmology : DJO·2021
Same author

Outcomes of primary trabeculectomy with mitomycin-C for primary angle closure glaucoma among supervised trainees in a tertiary eye center in Manila.

International ophthalmology·2021
Same author

Towards label-free 3D segmentation of optical coherence tomography images of the optic nerve head using deep learning.

Biomedical optics express·2020
Same author

Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial.

Acta ophthalmologica·2019
Same author

Orbital leiomyosarcoma metastasis presenting prior to diagnosis of the primary tumor.

Digital journal of ophthalmology : DJO·2018
Same journal

Contrast sensitivity and measuring cataract outcomes.

Ophthalmology clinics of North America·2006
Same journal

Capsular tension rings: update on endocapsular support devices.

Ophthalmology clinics of North America·2006
Same journal

Management of vitreous loss and dropped nucleus during cataract surgery.

Ophthalmology clinics of North America·2006
Same journal

Astigmatism control.

Ophthalmology clinics of North America·2006
Same journal

New technology IOL optics.

Ophthalmology clinics of North America·2006
Same journal

Phaco fluidics and phaco ultrasound power modulations.

Ophthalmology clinics of North America·2006
See all related articles

Selective laser trabeculoplasty (SLT) effectively lowers intraocular pressure in open-angle glaucoma. This safe and repeatable procedure offers an alternative to medications and other laser treatments.

Area of Science:

  • Ophthalmology
  • Glaucoma Management
  • Laser Therapy

Background:

  • Open-angle glaucoma requires effective intraocular pressure (IOP) reduction.
  • Traditional treatments include medications and argon laser trabeculoplasty (ALT).
  • Limitations of ALT include TM damage and non-repeatability.

Purpose of the Study:

  • To evaluate Selective Laser Trabeculoplasty (SLT) as a safe and effective IOP-lowering therapy.
  • To compare SLT with ALT and other glaucoma treatments.
  • To assess SLT's role in primary and adjunctive glaucoma management.

Main Methods:

  • SLT utilizes a large spot size for simplified treatment of the trabecular meshwork (TM).
  • The procedure aims to preserve TM architecture while reducing IOP.

Related Experiment Videos

  • SLT can be used as a primary treatment, an adjunct, or for failed ALT cases.

    • Main Results:

    • SLT is safe, well-tolerated, and effective in reducing IOP.
    • SLT preserves TM architecture, unlike ALT.
    • SLT is repeatable and may be effective after ALT failure.

    Conclusions:

    • SLT is a viable and safe alternative to ALT for open-angle glaucoma.
    • SLT can be considered for patients non-compliant with or intolerant to glaucoma medications.
    • SLT is effective as a primary treatment or adjunct therapy, without compromising future surgical success.